Back to top
more

Allergan plc (AGN)

(Delayed Data from NYSE)

$145.81 USD

145.81
1,518,334

+1.56 (1.08%)

Updated May 3, 2019 04:01 PM ET

After-Market: $145.88 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

[AGN]

Reports for Purchase

Showing records 161 - 180 ( 226 total )

Industry: Medical - Generic Drugs

Record: 161

07/11/2016

Company Report

Pages: 8

Price: 24.95

Industry: Medical - Generic Drugs

Record: 162

06/09/2016

Company Report

Pages: 8

Price: 24.95

Industry: Medical - Generic Drugs

Record: 163

05/12/2016

Company Report

Pages: 8

Price: 24.95

Industry: Medical - Generic Drugs

Record: 164

05/11/2016

Company Report

Pages: 2

Buyback Mountain - Buy

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Generic Drugs

Record: 165

04/08/2016

Company Report

Pages: 8

Price: 24.95

Industry: Medical - Generic Drugs

Record: 166

04/06/2016

Company Report

Pages: 2

Jack Lew Hosts ?Let?s Break a Deal

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Generic Drugs

Record: 167

03/17/2016

Company Report

Pages: 2

Spread Widens on Teva Delay - Buy

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Generic Drugs

Record: 168

03/07/2016

Company Report

Pages: 8

Price: 24.95

Industry: Medical - Generic Drugs

Record: 169

02/26/2016

Company Report

Pages: 7

Price: 24.95

Industry: Medical - Generic Drugs

Record: 170

02/23/2016

Company Report

Pages: 2

Pfizer and Anda Hit 2016 Outlook - Buy

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Generic Drugs

Record: 171

02/09/2016

Industry Report

Pages: 11

The Force (of Hillarycare) Awakens

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Generic Drugs

Record: 172

02/01/2016

Company Report

Pages: 8

Price: 24.95

Industry: Medical - Generic Drugs

Record: 173

01/25/2016

Industry Report

Pages: 10

Amitiza Tracker: Week Ended Jan. 15

Provider: H.C. Wainwright & Co., Inc.

Analyst: ARCE E

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Generic Drugs

Record: 174

12/30/2015

Company Report

Pages: 9

Price: 24.95

Industry: Medical - Generic Drugs

Record: 175

12/21/2015

Industry Report

Pages: 10

Amitiza Tracker: Week Ended Dec. 11

Provider: H.C. Wainwright & Co., Inc.

Analyst: ARCE E

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Generic Drugs

Record: 176

11/30/2015

Company Report

Pages: 9

Price: 24.95

Industry: Medical - Generic Drugs

Record: 177

11/24/2015

Company Report

Pages: 2

Allergan and Pfizer, the New Irish Kings - Buy

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Generic Drugs

Record: 178

11/16/2015

Company Report

Pages: 2

We are updating our estimates and sum-of-the-parts valuation for Allergan and continue to recommend shares

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Generic Drugs

Record: 179

10/30/2015

Company Report

Pages: 2

Pfizer Eyes Allergan - Buy

Provider: G.RESEARCH, LLC

Analyst: KEDRA K

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Generic Drugs

Record: 180

10/30/2015

Company Report

Pages: 8

Price: 24.95
// eof